Impact of denosumab on bone metastasis-free survival « THE "NEW" PROSTATE CANCER INFOLINK
Links shared publicly online about this topic.
- 273total visits
Impact of denosumab on bone metastasis-free survival « THE "NEW" PROSTATE CANCER INFOLINK
View full resource at prostatecancerinfolink.net
Tags: Cancer, Prostate Cancer, Bone, Osteoporosis Medication, Prostate, Men's Health, Prolia, Urology
Most Recently Shared on May 22, 2011 at 11:39 pm By:
Impact of denosumab on bone metastasis-free survival: A presentation at the American Urological Association annu... http://bit.ly/iSWF9F
Denosumab and Bone-Metastasis-Free Survival In Men With Castration-Resistant Prostate Cancer: Results of a Phase 3, Randomised, Placebo-Controlled Trial - OncologySTAT
oncologystat.com — “Lancet. 2011 Nov 15;[Epub Ahead of Print] - MR Smith, F Saad, R Coleman, N Shore, C Goessl, et al” View full resource at oncologystat.com
Most Recently Shared on December 1, 2011 at 5:29 pm By:
OncologySTAT Oncology and Health Site
Story of the Week: Denosumab and Bone–Metastasis-Free Survival In Advanced Prostate Cancer http://t.co/SvZu9qdW
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial : The Lancet
thelancet.com — “Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial. By - Prof Matthew R Smith MD, Prof Fred Saa...” View full resource at thelancet.com
Most Recently Shared on November 22, 2011 at 5:23 pm By:
Denosumab Lowers Bone Metastasis Risk in CRPC Patients - Renal and Urology News
renalandurologynews.com — “MONTREAL—Denosumab significantly prolongs bone metastasis-free survival (BMFS) and delays time to bone metastasis in men with castration-resistant prostate cancer (CRPC), according to data presented at the Canadian Urological Association annual meeting.” View full resource at renalandurologynews.com
Most Recently Shared on June 27, 2011 at 12:43 pm By:
Renal Urology News Health News, Nephrology, Urology, and Medical Publisher
Denosumab Lowers Bone Metastasis Risk in CRPC Patients: MONTREAL—Denosumab significantly prolongs bone metastasi... http://bit.ly/kirhJQ
Advertisement
